Acomplia and OTC orlistat for weight loss
March 2006
There's a lot of buzz about Acomplia and OTC orlistat for weight loss. Both could be approved as early as this summer.
Alli (AL-eye) will be OTC orlistat...half the strength of prescription Xenical.
GlaxoSmithKline hopes to market Alli for short-term use... 6 months or less...in people who are overweight.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote